Patents Assigned to Clarigen, Inc.
  • Patent number: 6803183
    Abstract: In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C10-C24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: October 12, 2004
    Assignee: Clarigen, Inc.
    Inventors: Marie-Claude Amoureux, Edit Hegyi, Peter Grandics, Susan Szathmary
  • Publication number: 20040014022
    Abstract: In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C10-C24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form.
    Type: Application
    Filed: July 18, 2002
    Publication date: January 22, 2004
    Applicant: Clarigen Inc.
    Inventors: Marie-Claude Amoureux, Edit Hegyi, Peter Grandics, Susan Szathmary
  • Patent number: 6251409
    Abstract: The present invention provides a decorative cosmetic composition that is visually distinct comprising a translucent or transparent particle and a cosmetic base. In addition, the present invention provides a decorative cosmetic composition that has both a functional effect, such as for cleansing or massage, and a distinct visual effect.
    Type: Grant
    Filed: November 10, 1998
    Date of Patent: June 26, 2001
    Assignee: Clarigen, Inc.
    Inventors: Edit Hegyi, Susan Szathmary, Peter Grandics